Cigna: Vanguard Reports 26.45M Shares (10.03%)
Cigna Group disclosed that The Vanguard Group filed an amendment to its Schedule 13G reporting beneficial ownership of 26,445,689 shares of common stock, representing 10.03% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cigna Group disclosed that The Vanguard Group filed an amendment to its Schedule 13G reporting beneficial ownership of 26,445,689 shares of common stock, representing 10.03% of the class.
The filing shows shared voting power of 2,785,837 shares and shared dispositive power over 26,445,689 shares. The filer notes an internal realignment effective January 12, 2026 that will lead certain Vanguard subsidiaries to report beneficial ownership separately.
Insights
Vanguard reports a 10.03% stake in Cigna with shared voting and dispositive authority.
The Schedule 13G/A lists 26,445,689 shares beneficially owned, with 2,785,837 shares of shared voting power and shared dispositive power reported at 26,445,689. This is an ownership disclosure under passive/investment manager rules.
The filing also documents a January 12, 2026 internal realignment at Vanguard that may lead to disaggregated reporting by subsidiaries; timing and scope of any separate subsidiary filings are not stated.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does The Vanguard Group report in Cigna (CI)?
Does the filing say Vanguard will change how it reports ownership?
Who signed the Schedule 13G/A for Vanguard on the CI filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.